Stop the Clot® – What Every Healthcare Professional Should Know
ORIGINATION DATE: October 10, 2016 EXPIRATION DATE: October 10, 2018
A. BACKGROUND INFORMATION
Program Description: This self-paced, online course provides the most current foundational information and clinical considerations to assess and treat patients with blood clots and clotting disorders, or those at risk of blood clots, to improve the ability of healthcare professionals to manage these patients.
Objectives: At the conclusion of the session, participants will be able to:
- Explain three signs and symptoms of clots, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Describe three factors that increase the risk of developing a blood clot in the form of a DVT and/or PE.
- Describe three management considerations for the use of anticoagulant medications.
- Explain three signs and symptoms of post-thrombotic syndrome that providers should include in patient education plans for blood clot survivors.
- Explain two facts about pulmonary hypertension and its relationship to DVT.
- Describe three appropriate treatment/management options to prevent clot re-currence and secondary complication.
Target Audience: Physicians, Nurses, Nurse Practitioners, Physician Assistants, Other Healthcare Professionals
Content: 1) Basics of Blood Clots 2) Thrombophilia & Blood Clots 3) Anticoagulation Medication 4) Post Thrombotic Syndrome 5) Pulmonary Hypertension 6) Prevention of Blood Clots
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use.
CME activities with Joint Providers:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and National Blood Clot Alliance. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 2.5 AMA PRA Category 1 Credits™.
The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 2.4 contact hours.
The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU’s for this program.
The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 2.5 Contact Hours in pharmacy education. The Universal Activity Number is 0387-9999-16-198-H01-P.
Category: This activity has been designated as Application-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
To use this online curriculum, you will need to enable cookies in your browser.
If you have already registered and are returning to continue your course please click here.
Please address questions or comments about the curriculum to email@example.com
The National Blood Clot Alliance developed and designed this curriculum with support provided by the Centers for Disease Control and Prevention under Cooperative Agreement 5U27DD000545.
C. IMPORTANT GUIDANCE: EVALUATION AND CONTINUING EDUCATION
Continuing education for this course is only available through the CDC Training and Continuing Education Online system (CDC TCEO). Please follow the instructions provided below. You must complete the online evaluation by October 10, 2018 to receive your continuing education or your certificate of completion.
To complete your online evaluation:
- Go to CDC TCEO at http://www.cdc.gov/tceonline/. Select Participant Login to login. If you are new to TCEO, select New Participant to create a user ID and password.
- Once logged on to CDC TCEO, the Participant Services page will display. Select the Search and Register Select a search method to locate the course and click on View.
- Click on the course name, and the course information page will display. Scroll down to Register Here. Select the type of CE that you would like to receive and then select Submit.
- The next page requests demographic information. New participants are required to answer the demographic questions. Returning participants please verify this information and select Submit.
- A message will display thanking you for registering for the course. If you have already completed the course you may select the option to take the evaluation.
- If you have not completed the course, you will be directed back to Participant Services. Under Evaluations and Tests you may access the course detail page, the course link, or the evaluation and/or posttest after completing the course
- Complete the evaluation and Submit. If a posttest is required it will follow the evaluation. A record of your course completion and your CE certificate will be posted in the Transcript and Certificate section, located on the Participant Services
If you have any questions or problems, please contact:
CDC/ATSDR Training and Continuing Education Online, 1-800-41TRAIN – Email at firstname.lastname@example.org
FEES: No fees are charged for CDC’s CE activities.
D. FACULTY/ CREDENTIALS:
- Mary Lou Damiano, RN, MA ,Co-Director, Hemophilia & Thrombosis Center, Univ of AZ, Consultant to National Blood Clot Alliance
- Kathleen McCool, PharmD, BCPS, CACP, Supervisor; Clinical Pharmacy Anticoagulation and Anemia Services, Kaiser Permanente Colorado
- Theresa Ransone, PA-C, MPAS, MT(ASCP)SH Thrombophilia Clinic, Gonda Vascular Center, Mayo Clinic, (Rochester, MN)
- Frederick R. Rickles, MD, FACP, Professor of Medicine, Pediatrics and Pharmacology and Physiology, The George Washington University
- Darren Triller, Pharm D., Senior Project Director for IPRO, the Centers for Medicare and Medicaid Services (CMS)-designated Quality Improvement Organization (QIO) for New York State
- Elizabeth Varga MS, CGC, Research Coordinator/Certified Genetic Counselor & Clinical Assistant Professor of Pediatrics, Center for Molecular and Human Genetics, The Research Institute at Nationwide Children’s Hospital
- Diane Wirth, MS ANP-BC CACP, Adult Nurse Practitioner with Provider Health Services and Consultant to National Blood Clot Alliance
DISCLOSURE: In compliance with continuing education requirements, all planners, presenters, and their spouses/partners must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of:
- Ms. Mary Lou Damiano, and she wishes to disclose that she receives honorarium from Biogen and Octapharma for serving on an advisory board
- Dr. Gary Raskob, and he wishes to disclose that he receives honorarium from Bayer, Janssen, J & J, BMS, Pfizer, and Daiichi Sankyo as a consultant and Advisory Board member
- Ms. Elizabeth Varga, and she wishes to disclose that she receives consulting payment from Bayer Pharmaceuticals and Express Scripts and honorarium from HealthEd
- Ms. Diane Wirth, and she wishes to disclose that she receives honorarium from Janssen Pharmaceuticals’ speakers’ bureau.
Planning committee discussed conflict of interest with Ms. Damiano, Ms. Varga, and Ms. Wirth to ensure there is no bias.
Planning committee reviewed the content that Dr. Raskob reviewed to ensure there is no bias.
The Centers for Disease Control and Prevention and National Blood Clot Alliance are jointly providing the CNE for this activity.
CDC did not accept commercial support for this continuing education activity.